Literature DB >> 11689132

Development and evaluation of high throughput functional assay methods for HERG potassium channel.

W Tang1, J Kang, X Wu, D Rampe, L Wang, H Shen, Z Li, D Dunnington, T Garyantes.   

Abstract

Three functional hERG channel assay methods have been developed and evaluated. The methods were tested against five known hERG channel inhibitors: dofetilide, terfenadine (Seldane), sertindole (Serdolect), astemizole (Hismanal), and cisapride (Propulsid). The DiBAC4(3)-based assays were found to be the most economical but had high false-hit rates as a result of the interaction of dye with the test compounds. The membrane potential dye assay had fewer color-quenching problems but was expensive and still gave false hits. The nonradioactive Rb+ efflux assay was the most sensitive of all the assays evaluated and had the lowest false-hit rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689132     DOI: 10.1177/108705710100600506

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  10 in total

1.  A fluorescent screening assay for identifying modulators of GIRK channels.

Authors:  Maribel Vazquez; Charity A Dunn; Kenneth B Walsh
Journal:  J Vis Exp       Date:  2012-04-24       Impact factor: 1.355

2.  Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels.

Authors:  Beiyan Zou; Haibo Yu; Joseph J Babcock; Pritam Chanda; Joel S Bader; Owen B McManus; Min Li
Journal:  Assay Drug Dev Technol       Date:  2010-12       Impact factor: 1.738

3.  Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay.

Authors:  Hai-bo Yu; Bei-yan Zou; Xiao-liang Wang; Min Li
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 4.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

Review 5.  Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.

Authors:  Richard B Rothman; Michael H Baumann; Thomas E Prisinzano; Amy Hauck Newman
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

Review 6.  Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective.

Authors:  C E Pollard; J-P Valentin; T G Hammond
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

7.  A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.

Authors:  Steven A Titus; Daniel Beacham; Sampada A Shahane; Noel Southall; Menghang Xia; Ruili Huang; Elizabeth Hooten; Yong Zhao; Louie Shou; Christopher P Austin; Wei Zheng
Journal:  Anal Biochem       Date:  2009-07-05       Impact factor: 3.365

8.  Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation.

Authors:  David J Diller; Doug W Hobbs
Journal:  J Comput Aided Mol Des       Date:  2007-06-05       Impact factor: 4.179

9.  A noninvasive optical approach for assessing chloride extrusion activity of the K-Cl cotransporter KCC2 in neuronal cells.

Authors:  Anastasia Ludwig; Claudio Rivera; Pavel Uvarov
Journal:  BMC Neurosci       Date:  2017-01-31       Impact factor: 3.288

10.  Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities.

Authors:  Saba Munawar; Monique J Windley; Edwin G Tse; Matthew H Todd; Adam P Hill; Jamie I Vandenberg; Ishrat Jabeen
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.